New concepts in the treatment of malignant pleural mesothelioma

Affiliations

¹ Division of Thoracic Surgery, Lung Center and International Mesothelioma Program, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Editorial

Moshe Lapidot et al. J Thorac Dis. 2018 Mar.

. 2018 Mar;10(3):1283-1285.

doi: 10.21037/jtd.2018.02.75.

¹ Division of Thoracic Surgery, Lung Center and International Mesothelioma Program, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

New Concepts in the Treatment of Malignant Pleural Mesothelioma.
Wald O, Sugarbaker DJ. Wald O, et al. Annu Rev Med. 2018 Jan 29;69:365-377. doi: 10.1146/annurev-med-041316-085813. Epub 2017 Oct 13. Annu Rev Med. 2018. PMID: 29029582 Review.

1. Beebe-Dimmer JL, Fryzek JP, Yee CL, et al. Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival. Clin Epidemiol 2016;8:743-50. 10.2147/CLEP.S105396 - DOI - PMC - PubMed
1. Krug LM. An overview of chemotherapy for mesothelioma. Hematol Oncol Clin North Am 2005;19:1117-36. 10.1016/j.hoc.2005.09.010 - DOI - PubMed
1. Kindler HL. Systemic treatments for mesothelioma: standard and novel. Curr Treat Options Oncol 2008;9:171-9. 10.1007/s11864-008-0071-3 - DOI - PMC - PubMed
1. Wald O, Sugarbaker DJ. New Concepts in the Treatment of Malignant Pleural Mesothelioma. Annu Rev Med 2018;69:365-77. 10.1146/annurev-med-041316-085813 - DOI - PubMed
1. Bölükbas S, Manegold C, Eberlein M, et al. Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy. Lung Cancer 2011;71:75-81. 10.1016/j.lungcan.2009.08.019 - DOI - PubMed